Sourasky Medical Center (Ichilov)
| Израиль | Түркия | Австрия | |
| Сүт безі рагында химиотерапия | бастап $22,500 | бастап $1,200 | бастап $15,000 |
| Нано-пышақ | бастап $18,500 | бастап $9,500 | бастап $25,000 |
| Тік ішек қатерлі ісігінде сәулелік терапия | - | бастап $7,000 | бастап $12,000 |
| Криодеструкция | - | бастап $3,500 | бастап $4,000 |
| Halcyon | - | бастап $5,400 | - |
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Радиотерапия институты директорының міндетін атқарушы ретінде доктор Гутфельд Сураски медициналық орталығының құрамындағы ірі онкологиялық орталықты басқарады.
Профессор Дан Флисс тамақ безінің қатерлі ісігі сияқты күрделі онкологиялық ауруларды емдеуге мамандандырылған Бас және мойын ісіктері орталығын басқарады. Ол үйлестірілген, көпсалалы көмек көрсету үшін өзінің хирургиялық және онкологиялық тәжірибесін ұштастырады.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Israel treats tonsil cancer using a multidisciplinary approach focused on organ preservation. Primary options include transoral robotic surgery, intensity-modulated radiation therapy, and chemotherapy. Advanced centers like Sourasky Medical Center report a 90% average success rate for oncology treatments through personalized, JCI-accredited care.
Bookimed Expert Insight: Israeli oncology centers demonstrate a clear pattern of high-volume specialization. Sourasky Medical Center performs 34,000 operations annually, while Assuta handles over 90,000. This immense surgical volume means teams are highly proficient in reconstructive techniques. Patients often find better functional outcomes here because surgeons perform these specific throat procedures daily.
Patient Consensus: Patients often note the speed of diagnosis, with PET/CT and specialist consultations completed in days. Many appreciate the focus on quality of life, specifically the efforts made to preserve their natural voice.
Tonsil cancer treatments in Israel frequently affect speaking and swallowing abilities. Surgery and radiation often cause temporary voice changes or difficult swallowing. Specialized Israeli clinics utilize Halcyon radiotherapy and robotic surgery to target tumors precisely. These methods help protect healthy throat tissues and preserve these vital functions.
Bookimed Expert Insight: Israeli oncology centers like Sourasky integrate specialized rehabilitation early to protect patient quality of life. Our data shows that top facilities use PET/CT-guided planning for every radiation session. This precision ensures high doses hit the tumor while missing the swallowing muscles. This dual-focus approach explains why major centers report a 90% oncology success rate.
Patient Consensus: Patients note it is important to practice swallowing exercises even when eating feels difficult. Many find that staying active with swallowing during radiation helps prevent long-term reliance on feeding tubes.
Israeli hospitals like Sourasky Medical Center and Assuta lead tonsil cancer care through JCI-accredited departments. Specialists utilize advanced robotic surgery and personalized radiotherapy to treat oropharyngeal malignancies. These centers report a 90% average success rate for oncology treatments while maintaining protocols for complex head and neck cases.
Bookimed Expert Insight: Israeli oncology centers like Sourasky maintain a massive scale with 2,200 doctors and 240 departments. This volume allows for narrow specialization in rare oropharyngeal sub-types. Data shows that public centers like Sourasky or Rambam are better suited for complex multidisciplinary needs. Private facilities like Assuta excel when patients require immediate surgical intervention without standard waiting periods.
Patient Consensus: Patients emphasize finding surgeons experienced in transoral robotic surgery to avoid invasive neck dissections. Many suggest seeking second opinions at high-volume centers to confirm if de-escalation protocols are appropriate for HPV-positive cases.
Clinical trials and experimental therapies are highly accessible in Israel. The country serves as a global research hub. Most major university-affiliated medical centers manage thousands of active trials. Patients can access innovative treatments through compassionate use pathways. These programs offer early access to non-registered therapies.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate for cancer treatments. This high outcome is partly due to doctors like Dr. Dan Fliss. He actively leads clinical trials in personalized medicine and immunotherapy. Patients should focus on clinics that involve their surgeons directly in research groups. This often provides faster access to genetic profiling for tailored protocols.
Patient Consensus: Patients note that while some local trials are government-subsidized, international visitors should budget for private fees. Many emphasize the benefit of clinical trials for HPV-positive tonsil cancer treatment.
Israeli medical centers use transoral robotic surgery (TORS) and laser microsurgery to perform precise tonsil cancer resections. These minimally invasive techniques access tumors through the mouth without large external incisions. This approach helps preserve critical functions like speech and swallowing while accelerating recovery times.
Bookimed Expert Insight: Data from major Israeli centers shows a 90% oncology success rate through departmental integration. Specialists like Dr. Orit Gutfeld at Sourasky Medical Center combine radiotherapy with robotic resections. This synergy often allows for treatment de-escalation, meaning lower radiation doses for patients. Smaller centers often focus on single modalities, while these high-volume facilities offer both TORS and MR-Linac technologies.
Patient Consensus: Patients note it is important to choose teams with high case volumes to avoid temporary swallowing issues. Many emphasize that pre-operative speech therapy planning contributes significantly to their long-term recovery success.
Recovery after tonsil cancer treatment in Israel involves multidisciplinary teams focusing on speech, swallowing, and nutritional restoration. Rehabilitation usually begins immediately after surgery or radiotherapy at JCI-accredited centers. Specialized therapists help patients regain 80% of function within six months through intensive voice and physical therapy protocols.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate in oncology treatments. This high success is partly due to their massive patient volume of 400,000+ individuals annually. Large centers often offer more robust physical therapy departments. For example, Dr. Dan Fliss at Sourasky specializes in both surgery and maxillofacial rehabilitation. Choosing such multidisciplinary experts ensures your surgical recovery and functional rehabilitation are managed by the same clinical team.
Patient Consensus: Patients note that recovery takes 6 to 12 months and emphasize the importance of using humidifiers. Many suggest stockpiling high-calorie shakes early and using support groups to manage the emotional impact of voice changes.
Patients can receive a remote treatment plan for tonsil cancer from Israeli centers before traveling. Major hospitals use telemedicine to review medical records and pathology. This helps determine the preliminary surgical or radiation strategy. A video consultation often includes specialized oncologists and surgeons.
Bookimed Expert Insight: While public centers like Sourasky (Ichilov) handle huge volumes, private centers like Assuta allow patients to pre-select their specific surgeon or room type. Our data shows that top Israeli oncologists often hold PhDs and lead clinical trials. This high level of specialization ensures that remote plans align with the latest immunotherapy research.
Patient Consensus: Patients note it is vital to upload all diagnostic records early to avoid delays. Many emphasize that while remote plans provide a helpful roadmap, these strategies often adjust once in-person biopsies are performed in Israel.